Dawn Christine Maroney Sells 100,000 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 100,000 shares of the business’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $20.03, for a total transaction of $2,003,000.00. Following the sale, the president owned 1,285,167 shares in the company, valued at $25,741,895.01. This trade represents a 7.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The shares were sold at an average price of $21.33, for a total transaction of $4,866,482.16.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80.
• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.01, for a total transaction of $2,267,513.19.
• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.02, for a total transaction of $333,953.62.

Alignment Healthcare Stock Up 1.4%

Shares of NASDAQ ALHC traded up $0.30 during mid-day trading on Tuesday, hitting $21.30. The company had a trading volume of 3,772,138 shares, compared to its average volume of 3,136,679. The company has a market capitalization of $4.26 billion, a PE ratio of -177.50, a price-to-earnings-growth ratio of 5.81 and a beta of 1.16. The business’s 50-day simple moving average is $18.43 and its 200 day simple moving average is $16.38. Alignment Healthcare, Inc. has a 1-year low of $11.35 and a 1-year high of $21.65. The company has a debt-to-equity ratio of 1.99, a current ratio of 1.61 and a quick ratio of 1.61.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, October 30th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.03. The firm had revenue of $993.70 million during the quarter, compared to analysts’ expectations of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.Alignment Healthcare’s revenue for the quarter was up 43.5% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.14) EPS. On average, analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ALHC has been the topic of several analyst reports. Zacks Research cut shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 28th. Piper Sandler raised their price objective on shares of Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a report on Tuesday. JPMorgan Chase & Co. lifted their price objective on shares of Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. UBS Group increased their target price on Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a report on Friday, October 31st. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $22.00 price target on shares of Alignment Healthcare in a report on Monday, November 3rd. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $21.25.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. Larson Financial Group LLC purchased a new stake in Alignment Healthcare in the third quarter valued at $33,000. SBI Securities Co. Ltd. grew its holdings in shares of Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after purchasing an additional 2,970 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Alignment Healthcare by 83.8% during the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after purchasing an additional 987 shares in the last quarter. KBC Group NV purchased a new stake in shares of Alignment Healthcare in the 2nd quarter valued at about $44,000. Finally, Signaturefd LLC boosted its position in shares of Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after purchasing an additional 2,215 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.